Healthy Soch
Systemic Reforms to Protect Transfusion-Dependent Patients
India
healthysoch
New Delhi, January 14, 2026:
The Thalassaemia Patients Advocacy Group (TPAG) today formally announced the launch of its comprehensive position paper titled “Ensuring Safe Blood for All: Strengthening Blood Safety Practices,” following a high-level strategic dialogue convened in New Delhi.
The position paper has been developed with contributions from a diverse group of eminent experts and advocates, including Prof. N.K. Ganguly, Former Director-General, Indian Council of Medical Research (ICMR); Prof. Bejon Kumar Misra, Public Health Advocate; Suneha Paul, Thalassemia Patient Advocate; P.C. Sen, Senior Advocate, Supreme Court of India; and Tuhin A. Sinha, National Spokesperson, Bharatiya Janata Party (BJP). It consolidates patient experiences, scientific evidence, legal perspectives, and public health expertise into a unified, action-oriented roadmap to strengthen India’s blood safety ecosystem and safeguard the lives of transfusion-dependent patients, particularly those living with thalassemia.
The position paper underscores that safe, timely, and equitable access to blood is not merely a clinical requirement but a fundamental issue of survival, dignity, and constitutional responsibility. For individuals with thalassemia who require lifelong, regular blood transfusions, gaps in screening protocols, uneven access to advanced diagnostic technologies, and fragmented regulation pose serious and preventable risks, including transfusion-transmitted infections such as HIV and Hepatitis B and C. TPAG’s paper positions blood safety as a foundational pillar of India’s healthcare infrastructure that must be addressed proactively rather than reactively.
Drawing on deliberations with policymakers, clinicians, scientists, legal experts, and patient advocates, the paper highlights persistent systemic challenges, including the non-uniform adoption of Nucleic Acid Testing (NAT) across blood banks, the absence of a consolidated national blood law, inequitable access to safe blood in rural and underserved regions, and limited transparency and accountability within the transfusion system. It argues that these gaps collectively undermine patient trust and expose vulnerable populations to avoidable harm.
The paper sets out a clear set of recommendations aimed at driving national reform. These include mandating Nucleic Acid Testing across all blood banks to minimise window-period infections and harmonise screening standards nationwide; enacting a comprehensive and enforceable Blood Safety Act to codify patient rights and institutional responsibilities; launching a dedicated National Thalassemia Control Programme to integrate prevention, screening, and long-term care; ensuring thalassemia patients receive meaningful employment protections under existing disability frameworks; and accelerating indigenous gene therapy research to offer long-term curative solutions while ensuring affordability and access.
Speaking on the occasion, Deepak Chopra, Mentor, Thalassemia Patients Advocacy Group (TPAG), said, “This is not only about healthcare systems, it is about dignity, equity, and the right to safe, life-saving interventions. For thalassemia patients, every transfusion carries hope but also fear when safety is not assured. Our position paper is a call to place patient lives at the centre of policy, to move blood safety from the margins to the mainstream of healthcare governance, and to ensure that preventable risks are eliminated through science, law, and accountability.”
TPAG reaffirmed its commitment to working constructively with the Ministry of Health and Family Welfare, state governments, healthcare institutions, and civil society to translate these recommendations into actionable policy and on-ground implementation. The organisation emphasised that ensuring safe blood for all is both a public health imperative and a matter of social justice, requiring sustained political will, scientific investment, and meaningful patient participation in decision-making processes.
The position paper concludes with a clear message that India has both the capacity and the responsibility to build a resilient, transparent, and equitable blood safety system. With coordinated action and evidence-based reforms, safe blood can and must become a guaranteed national standard rather than an uneven privilege.
